- $18.74bn
- $17.19bn
- $3.32bn
- 77
- 42
- 82
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,063 | 2,711 | 2,923 | 2,619 | 3,319 |
Cost of Revenue | |||||
Gross Profit | 549 | 681 | 730 | 128 | 1,301 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,225 | 2,394 | 2,337 | 2,647 | 2,461 |
Operating Profit | -162 | 317 | 587 | -27.2 | 857 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -120 | 293 | 572 | 8.6 | 891 |
Provision for Income Taxes | |||||
Net Income After Taxes | -115 | 400 | 469 | -44.2 | 831 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -115 | 398 | 469 | -44.2 | 831 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -115 | 398 | 469 | -44.2 | 831 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.15 | 3.77 | 3.26 | -1.61 | 7.99 |